A 12-month clinical investigation with a 24-day regimen containing 15 μg ethinylestradiol plus 60 μg gestodene with respect to hemostasis and cycle control

This publication has 13 references indexed in Scilit:

• Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)
  American Journal of Obstetrics and Gynecology, 1999
• A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 μg desogestrel or 30 μg levonorgestrel
  Contraception, 1998
• A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and tolerance
  Contraception, 1997
• Evaluation of the prethrombotic statein pregnancy and in women using oral contraceptives
  Contraception, 1996
• The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives
  BJOG: An International Journal of Obstetrics and Gynaecology, 1996
• A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol
  Contraception, 1996
• Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women
  American Journal of Obstetrics and Gynecology, 1993
• Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus
  Thrombosis Research, 1992
• A comparative study on the effects of a monophasic pill containing desogestrel plus 20 μg ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors
  Contraception, 1991
• Fibrinopeptide a plasma levels during low-estrogen oral contraceptive treatment
  Contraception, 1984